Mehdizadegan Nima, Mohammadi Hamid, Amoozgar Hamid, Pournajaf Samira, Edraki Mohammad Reza, Naghshzan Amir, Yazdani Mohammad Nima
Department of Pediatrics, School of Medicine Shiraz University of Medical Sciences Shiraz Iran.
Neonatology Research Center Shiraz University of Medical Sciences Shiraz Iran.
Health Sci Rep. 2022 May 23;5(3):e652. doi: 10.1002/hsr2.652. eCollection 2022 May.
We reinvestigated the causes, symptoms, and management of childhood pericardial effusion (PE) and its gradual changes during recent years in a referral pediatric cardiology center in the south of Iran.
We retrospectively analyzed the profile of PE patients who were under 18 years old from 2015 to 2020. The patient's demographic, clinical, and paraclinical information was extracted and analyzed using SPSS software.
In general, 150 out of 63,736 admitted patients (0.23% of the total pediatric admissions) were diagnosed with PE (male/female 1:1.17). The median age was 3.25 years (range:\ 2 days to 18 years; interquartile range: 9.5), and 50% of them were under 3 years of age. 32.6% had moderate to severe PE. Most patients presented with acute symptoms (68%) and respiratory problems, as the most common symptoms (30.6%). Tamponade signs were presented in 2% ( = 3) of the patients, and 80.7% ( = 121) were in a stable hemodynamic condition. In total, renal failure (22%) and parapneumonic effusion were the leading etiologies. Viral (7%) and bacterial (5%) pericarditis were the seventh and eighth causes; however, in severe cases, renal failure (22%) and bacterial pericarditis (14%) were dominant. In total, 14.1% ( = 21) of the patients needed pericardiocentesis that increased to 78.3% ( = 18) in severe cases. Only 6% had persistent PE for more than 3 months.
Childhood PE is mostly a result of renal failure and noninfectious causes. True pericarditis cases are not common, except in severe cases. It is more common in less than 3-year-old patients, and chronicity is rare. Severe cases had a high chance of pericardiocentesis, but other cases were mainly managed by treatment of the underlying causes.
我们在伊朗南部一家转诊儿科心脏病中心,重新调查了儿童心包积液(PE)的病因、症状、治疗方法及其近年来的逐渐变化情况。
我们回顾性分析了2015年至2020年期间18岁以下PE患者的资料。使用SPSS软件提取并分析患者的人口统计学、临床和辅助检查信息。
总体而言,63736名入院患者中有150例(占儿科入院总数的0.23%)被诊断为PE(男/女为1:1.17)。中位年龄为3.25岁(范围:2天至18岁;四分位间距:9.5),其中50%的患者年龄在3岁以下。32.6%的患者患有中度至重度PE。大多数患者表现为急性症状(68%),呼吸问题是最常见的症状(30.6%)。2%(n = 3)的患者出现心包填塞体征,80.7%(n = 121)的患者血流动力学稳定。总体而言,肾衰竭(22%)和肺炎旁积液是主要病因。病毒性(7%)和细菌性(5%)心包炎分别是第七和第八大病因;然而,在严重病例中,肾衰竭(22%)和细菌性心包炎(14%)占主导地位。总体而言,14.1%(n = 21)的患者需要进行心包穿刺术,在严重病例中这一比例增至78.3%(n = 18)。只有6%的患者持续性PE超过3个月。
儿童PE主要是肾衰竭和非感染性病因所致。真正的心包炎病例并不常见,严重病例除外。在3岁以下患者中更为常见,慢性病例罕见。严重病例心包穿刺术的可能性较高,但其他病例主要通过治疗潜在病因进行处理。